Halozyme Therapeutics shares owned by Raymond James Financial
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Raymond James Financial
from 13F filings
Historical chart of Raymond James Financial investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Raymond James Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $21M | 281k | 73.34 |
| 2025-06-30 | $13M | 252k | 52.02 |
| 2025-03-31 | $20M | 307k | 63.81 |
| 2024-12-31 | $22M | 457k | 47.81 |